Cholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in people older than age 50. It is often diagnosed when it is advanced, ...

This post was updated Feb. 24 at 11:40 p.m. Dr. Vatche Agopian, a liver transplant hepatobiliary surgeon at UCLA, sat down with Daily Bruin contributor Donya Hassanshahi during February’s Gallbladder ...

LAFAYETTE, La. — It's Gallbladder and Bile Duct Cancer Awareness month, shining a light on these rare but serious cancers. These cancers are often linked to gallstones, long-term inflammation and ...

Sydney Towle shared a heartbreaking bile duct cancer update while raising awareness about cholangiocarcinoma symptoms, ...

By Andria Park Huynh HealthDay ReporterMONDAY, May 11, 2026 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in ...

Sian Ashcroft died last year aged 35 just 18 days after she was diagnosed with cholangiocarcinoma (CCA), a form of liver cancer A mother of three who died days after receiving a liver cancer diagnosis ...

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will ...

If you or a loved one has gallbladder or bile duct cancer, you may be interested in learning more about treatments for it. For a long time, the standard treatment options for this cancer type were ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved Bizengri for adults with advanced, metastatic or unresectable NRG1 fusion-positive ...

The annual cancer statistics report from the National Cancer Institute (NCI) — which was published in the journal Cancer on Monday, April 21 — shows some signs of progress in America’s fight against ...

May 8 (Reuters) - The U.S. Food and Drug Administration has approved Partner Therapeutics' drug for adults with a rare form of bile duct ‌cancer as part of a new fast-track review program, the agency ...